209 related articles for article (PubMed ID: 12417023)
1. RNase 3 (ECP) is an extraordinarily stable protein among human pancreatic-type RNases.
Maeda T; Mahara K; Kitazoe M; Futami J; Takidani A; Kosaka M; Tada H; Seno M; Yamada H
J Biochem; 2002 Nov; 132(5):737-42. PubMed ID: 12417023
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.
Domachowske JB; Dyer KD; Adams AG; Leto TL; Rosenberg HF
Nucleic Acids Res; 1998 Jul; 26(14):3358-63. PubMed ID: 9649619
[TBL] [Abstract][Full Text] [Related]
3. Endocytotic internalization as a crucial factor for the cytotoxicity of ribonucleases.
Leich F; Stöhr N; Rietz A; Ulbrich-Hofmann R; Arnold U
J Biol Chem; 2007 Sep; 282(38):27640-6. PubMed ID: 17635931
[TBL] [Abstract][Full Text] [Related]
4. Ribonuclease activity and substrate preference of human eosinophil cationic protein (ECP).
Sorrentino S; Glitz DG
FEBS Lett; 1991 Aug; 288(1-2):23-6. PubMed ID: 1715291
[TBL] [Abstract][Full Text] [Related]
5. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
6. Tandemization endows bovine pancreatic ribonuclease with cytotoxic activity.
Leich F; Köditz J; Ulbrich-Hofman R; Arnold U
J Mol Biol; 2006 May; 358(5):1305-13. PubMed ID: 16580680
[TBL] [Abstract][Full Text] [Related]
7. RNase A ribonucleases and host defense: an evolving story.
Rosenberg HF
J Leukoc Biol; 2008 May; 83(5):1079-87. PubMed ID: 18211964
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic RNase inhibitor only affects RNases with intrinsic cytotoxicity.
Monti DM; D'Alessio G
J Biol Chem; 2004 Sep; 279(38):39195-8. PubMed ID: 15277533
[TBL] [Abstract][Full Text] [Related]
9. The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity.
Gullberg U; Widegren B; Arnason U; Egesten A; Olsson I
Biochem Biophys Res Commun; 1986 Sep; 139(3):1239-42. PubMed ID: 3768000
[TBL] [Abstract][Full Text] [Related]
10. Kinetic and thermodynamic thermal stabilities of ribonuclease A and ribonuclease B.
Arnold U; Ulbrich-Hofmann R
Biochemistry; 1997 Feb; 36(8):2166-72. PubMed ID: 9047316
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of human RNase 1 by introduction of a disulfide bond between residues 4 and 118.
Futami J; Tada H; Seno M; Ishikami S; Yamada H
J Biochem; 2000 Aug; 128(2):245-50. PubMed ID: 10920260
[TBL] [Abstract][Full Text] [Related]
12. Double-stranded RNA: the variables controlling its degradation by RNases.
Yakovlev GI; Sorrentino S; Moiseyev GP; Libonati M
Nucleic Acids Symp Ser; 1995; (33):106-8. PubMed ID: 8643340
[TBL] [Abstract][Full Text] [Related]
13. Single-strand-preferring RNases degrade double-stranded RNAs by destabilizing its secondary structure.
Yakovlev G; Moiseyev GP; Sorrentino S; De Prisco R; Libonati M
J Biomol Struct Dyn; 1997 Oct; 15(2):243-50. PubMed ID: 9399152
[TBL] [Abstract][Full Text] [Related]
14. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
Leonidas DD; Chavali GB; Oikonomakos NG; Chrysina ED; Kosmopoulou MN; Vlassi M; Frankling C; Acharya KR
Protein Sci; 2003 Nov; 12(11):2559-74. PubMed ID: 14573867
[TBL] [Abstract][Full Text] [Related]
15. Ribonuclease and ribonuclease inhibitor in the human pancreas.
Kiyohara H; Menjo M
Gastroenterol Jpn; 1983 Jun; 18(3):252-4. PubMed ID: 6307804
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the angiogenic activity of zebrafish ribonucleases.
Monti DM; Yu W; Pizzo E; Shima K; Hu MG; Di Malta C; Piccoli R; D'Alessio G; Hu GF
FEBS J; 2009 Aug; 276(15):4077-90. PubMed ID: 19549190
[TBL] [Abstract][Full Text] [Related]
17. Preparation of potent cytotoxic ribonucleases by cationization: enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups.
Futami J; Maeda T; Kitazoe M; Nukui E; Tada H; Seno M; Kosaka M; Yamada H
Biochemistry; 2001 Jun; 40(25):7518-24. PubMed ID: 11412105
[TBL] [Abstract][Full Text] [Related]
18. Modification of the unfolding region in bovine pancreatic ribonuclease and its influence on the thermal stability and proteolytic fragmentation.
Arnold U; Schierhorn A; Ulbrich-hofmann R
Eur J Biochem; 1999 Jan; 259(1-2):470-5. PubMed ID: 9914529
[TBL] [Abstract][Full Text] [Related]
19. Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor.
Naddeo M; Vitagliano L; Russo A; Gotte G; D'Alessio G; Sorrentino S
FEBS Lett; 2005 May; 579(12):2663-8. PubMed ID: 15862306
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
Johnson RJ; McCoy JG; Bingman CA; Phillips GN; Raines RT
J Mol Biol; 2007 Apr; 368(2):434-49. PubMed ID: 17350650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
